Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study
帕博利珠单抗一线治疗复发性局部晚期或转移性默克尔细胞癌:单臂、开放标签、III期KEYNOTE-913研究结果
期刊:American Journal of Clinical Dermatology
影响因子:8.8
doi:10.1007/s40257-024-00885-w
Mortier, Laurent; Villabona, Lisa; Lawrence, Ben; Arance, Ana; Butler, Marcus O; Beylot-Barry, Marie; Saiag, Philippe; Samimi, Mahtab; Ascierto, Paolo A; Spada, Francesca; De Pontville, Michel; Maio, Michele; Berrocal, Alfonso; Espinosa, Enrique; Capdevila, Jaume; Levin, Max; Das, Debasmita; Krepler, Clemens; Grebennik, Dmitri; Chiarion-Sileni, Vanna